Across England, nearly £190 million has been paid out over five years to settle 870 claims of cancer misdiagnosis — a figure that speaks not only to institutional failure but to the irreversible weight of time lost. Behind each settlement is a moment when a symptom was dismissed, a test not ordered, a life redirected toward a harder fate. The story of Helen Dutton, who died at 40 after her rectal cancer went undetected for two years, reminds us that the cost of a missed diagnosis is rarely measured in money alone. As the NHS grapples with targets unmet for a decade, the question before it is w
NHS cancer misdiagnosis payouts hit £190m as delayed diagnoses claim lives
I would rather be poor and have Helen still around
Why does a two-year delay matter so much for rectal cancer specifically?
Because cancer doesn't stay in one place. In Helen's case, those two years allowed it to progress from something potentially treatable to stage 4—meaning it had already begun spreading to other parts of her body. By the time she was finally diagnosed, the treatment options were far more aggressive and her chances of long-term survival were drastically reduced.
The GP saw blood in her stool and didn't refer her. That seems like a basic clinical decision.
It does. Blood in stool is a red flag that demands investigation. The GP attributed it to haemorrhoids—a common, benign condition—without ruling out anything more serious. That's the gap: the assumption that a symptom has an obvious cause, without the step of actually checking.
Darren says he'd rather be poor. Do you think the compensation is actually insulting to him?
Not insulting exactly, but hollow. He lost his partner, his daughter lost her mother, and he's been unable to work for five years because of trauma. No amount of money restores what was taken. The settlement acknowledges the NHS made a mistake, but it can't undo the mistake.
Why are the average payouts going up if fewer cases are being settled each year?
Because the cases that do go to settlement now involve greater harm. Younger people are being affected, which means longer lives disrupted. Some survivors need ongoing care for mobility or fertility issues. The harm is deeper, so the compensation reflects that.
The NHS missed its treatment targets since 2015. That's over a decade of failure.
Yes. And that's just the formal targets—the cases that reach court are the ones where things went catastrophically wrong. There are likely many more people whose diagnoses were delayed but who didn't sue, or whose outcomes were less severe.
What would actually fix this?
Faster access to diagnostic testing, better training for GPs on red flag symptoms, and systems that catch missed results before they become fatal delays. But that requires resources the NHS doesn't currently have.
El Pulso
- A GP's dismissal of blood in stool and bowel changes as IBS left a 35-year-old woman's rectal cancer undetected for two years, by which point it had reached stage 4.
- Helen Dutton survived chemotherapy, surgery, and an all-clear — only for the cancer to return two months later, killing her at 40 and leaving her partner and daughter with PTSD and financial ruin.
- NHS cancer misdiagnosis payouts have nearly doubled in five years, rising from £32 million to £41.3 million annually, with average settlements climbing 20 percent as delays cause increasingly severe harm.
- The NHS has not met its two-month urgent cancer referral-to-treatment target since 2015, exposing a systemic gap between policy ambition and the reality patients face.
- The government points to 82,000 more timely diagnoses in the past year, but legal specialists warn that rising settlement costs signal a system still failing patients in ways money cannot repair.
Across England, nearly £190 million has been paid out over five years to settle 870 claims of cancer misdiagnosis — a figure that speaks not only to institutional failure but to the irreversible weight of time lost. Behind each settlement is a moment when a symptom was dismissed, a test not ordered, a life redirected toward a harder fate. The story of Helen Dutton, who died at 40 after her rectal cancer went undetected for two years, reminds us that the cost of a missed diagnosis is rarely measured in money alone. As the NHS grapples with targets unmet for a decade, the question before it is whether systems can be reformed quickly enough to spare the next family from the same grief.
Darren Rosheski's partner Helen Dutton was 35, a finance manager and mother, when she first visited her GP in late 2016 with blood in her stool, back pain, and changes to her bowel habits. The doctor attributed her symptoms to IBS and haemorrhoids and sent her home without further investigation. Two years passed before she saw a different GP, who referred her immediately. The tests that followed — CT scans, MRI, colonoscopy — revealed what should have been found in 2016: rectal cancer, already at stage 4.
Dutton underwent chemotherapy, radiotherapy, and surgery at Manchester's Christie hospital, and in June 2020 received an all-clear. Two months later the cancer returned. She died in August 2021, aged 40. Rosheski, who had depended entirely on her income, sued the NHS through Irwin Mitchell solicitors. The case settled out of court in January for an undisclosed sum. "I would rather be poor and have Helen still around," he said. "A family has been destroyed by a doctor's negligence." Both he and their daughter have since been diagnosed with PTSD and complex grief; he has worked for only one month in five years.
His story arrived alongside figures obtained through a freedom of information request to NHS Resolution. Over the past five years, the NHS in England paid nearly £190 million to settle 870 cancer misdiagnosis or delayed diagnosis claims. Annual costs have risen from £32 million in 2020–21 to £41.3 million in 2024–25, and average payouts have climbed 20 percent to roughly £241,000 — a sign that delays are producing increasingly severe harm. Medical negligence specialist Olivia Boschat, who obtained the data, described the numbers as alarming, noting that behind them lie lives cut short by errors that were, in many cases, preventable.
The NHS has not met its target of beginning treatment within two months of an urgent cancer referral since December 2015, nor its 31-day treatment-start target since December 2020. The Department of Health acknowledged that early, accurate diagnosis is essential and pointed to 82,000 more timely diagnoses in the past year. But for families like Rosheski's, the gap between institutional progress and personal catastrophe remains vast — and no settlement can close it.
Darren Rosheski remembers the moment a consultant at Tameside hospital told his partner Helen Dutton that her symptoms were serious enough to warrant immediate investigation. The doctor had found a large lump in her colon and used the word "sinister." But that conversation came two years too late. By then, the cancer had already begun to spread.
Dutton first saw her GP in late 2016 with symptoms that should have raised alarms: blood in her stool, back pain, and changes to her bowel habits. The family doctor dismissed them as irritable bowel syndrome and haemorrhoids, offering no further tests or referrals. She was 35 years old, a finance manager and mother of one. The misdiagnosis would cost her everything.
Two years passed before Dutton returned to her GP surgery and saw a different doctor. This time she was referred to the hospital. The tests came quickly then—CT scans, MRI scans, a colonoscopy—and they revealed what should have been found in 2016: rectal cancer, already at stage 4. Three weeks later, doctors at Manchester's Christie cancer hospital confirmed the worst. Dutton underwent chemotherapy, radiotherapy, and surgery. In June 2020, she received the all-clear. But two months later, the cancer returned. She died in August 2021, aged 40.
Rosheski, a tradesman, sued the NHS through Irwin Mitchell solicitors. He and their daughter had depended entirely on Dutton's income. The case settled out of court in January for an undisclosed sum. But money, he says, is meaningless. "I would rather be poor and have Helen still around," he told those investigating the case. "A family has been destroyed by a doctor's negligence. I don't care about the compensation. I just wish she was here now." Both he and their daughter have struggled with serious mental health problems since her death. Rosheski has worked for only a month in the five years since, his diagnosed PTSD and complex grief making employment impossible.
Rosheski's story arrived as new figures revealed the scale of the problem across the NHS. Over the past five years, the health service in England has paid out nearly £190 million to settle 870 claims involving cancer misdiagnosis or delayed diagnosis. The annual cost has nearly doubled, rising from £32 million in 2020-21 to £41.3 million in 2024-25. The average payout per case has climbed 20 percent, from roughly £200,000 to £241,705, suggesting that delays are causing increasingly severe harm.
Olivia Boschat, a medical negligence specialist at Bolt Burdon Kemp, obtained these figures through a freedom of information request to NHS Resolution, the agency handling medical negligence claims. She described the numbers as alarming. "Behind these figures lie heartbreak, tragedy and, in some cases, lives cut short—lives that could have been saved but, because of errors and negligence, were ended prematurely," she said. The difficulties patients face accessing urgent cancer testing are often central to these lawsuits. Some delays are unavoidable as doctors rule out other diagnoses, but others stem from overlooked symptoms, tests not carried out quickly enough, or results that are missed or ignored. The consequences can be catastrophic: cancers spread, requiring more aggressive treatment, and in the worst cases become untreatable.
The NHS has failed to meet its own targets for years. Since December 2020, it has not met the goal of starting urgent cancer treatment within 31 days of a patient and doctor agreeing on a plan. It has not met the target of starting treatment within two months of receiving a suspected urgent cancer referral since December 2015. Guy Forster, president of the Association of Personal Injury Lawyers, noted that surviving victims often need additional care, therapies, and equipment if delays have caused mobility or continence problems. Many are unable to work for extended periods. For those who have lost loved ones, he said, "lives will be turned upside down, partners and their children may be without the practical, emotional and financial support on which they are reliant."
The Department of Health and Social Care acknowledged that mistakes happen and that early, accurate diagnosis is essential to effective cancer treatment. A spokesperson said the government is committed to addressing the problem, noting that 82,000 more people received timely diagnoses or all-clears in the last year compared to the year before. But the rising cost of settlements and the mounting human toll suggest the system remains broken in ways that compensation alone cannot fix.
Citas Notables
I lost her because nobody listened to her. It came down to the GP not listening to her. They should have investigated her when she first saw the GP.— Darren Rosheski, partner of Helen Dutton
Behind these figures lie heartbreak, tragedy and, in some cases, lives cut short—lives that could have been saved but, because of errors and negligence, were ended prematurely.— Olivia Boschat, medical negligence specialist at Bolt Burdon Kemp